Clinical Trial Update: Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and tolerability of cilofexor in participants with primary sclerosing cholangitis and compensated cirrhosis; study terminated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Compensated Cirrhosis
• Sclerosing Cholangitis

Drugs mentioned

• Cilofexor (cilofexor)

Snippet

Sponsor: Gilead Sciences | Conditions: Primary Sclerosing Cholangitis, Compensated Cirrhosis | Phase 1 | Status: TERMINATED | Results posted: 2023-07-27